Drug screens and CRISPR combine to help make better cancer drugs
A new study has created the most comprehensive analysis for understanding how cancer drugs work at a molecular level. Scientists at the Wellcome Sanger Institute, EMBL's European Bioinformatics Institute (EMBL-EBI) and AstraZeneca ...
Jul 7, 2020
0
163